Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1216052.RAkF0qeHx6uRpmMBsq8ktf3c1yI-jl4O5V02wqWyGKI-s130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1216052.RAkF0qeHx6uRpmMBsq8ktf3c1yI-jl4O5V02wqWyGKI-s130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1216052.RAkF0qeHx6uRpmMBsq8ktf3c1yI-jl4O5V02wqWyGKI-s130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1216052.RAkF0qeHx6uRpmMBsq8ktf3c1yI-jl4O5V02wqWyGKI-s130_provenance.
- NP1216052.RAkF0qeHx6uRpmMBsq8ktf3c1yI-jl4O5V02wqWyGKI-s130_assertion description "[Antibodies targeting CD160-GPI complement the blockade of PD-1 to enhance HIV-specific T-cell responses and warrant further investigation in the development of novel immunotherapeutic approaches.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1216052.RAkF0qeHx6uRpmMBsq8ktf3c1yI-jl4O5V02wqWyGKI-s130_provenance.
- NP1216052.RAkF0qeHx6uRpmMBsq8ktf3c1yI-jl4O5V02wqWyGKI-s130_assertion evidence source_evidence_literature NP1216052.RAkF0qeHx6uRpmMBsq8ktf3c1yI-jl4O5V02wqWyGKI-s130_provenance.
- NP1216052.RAkF0qeHx6uRpmMBsq8ktf3c1yI-jl4O5V02wqWyGKI-s130_assertion SIO_000772 25179432 NP1216052.RAkF0qeHx6uRpmMBsq8ktf3c1yI-jl4O5V02wqWyGKI-s130_provenance.
- NP1216052.RAkF0qeHx6uRpmMBsq8ktf3c1yI-jl4O5V02wqWyGKI-s130_assertion wasDerivedFrom befree-2016 NP1216052.RAkF0qeHx6uRpmMBsq8ktf3c1yI-jl4O5V02wqWyGKI-s130_provenance.
- NP1216052.RAkF0qeHx6uRpmMBsq8ktf3c1yI-jl4O5V02wqWyGKI-s130_assertion wasGeneratedBy ECO_0000203 NP1216052.RAkF0qeHx6uRpmMBsq8ktf3c1yI-jl4O5V02wqWyGKI-s130_provenance.
- befree-2016 importedOn "2016-02-19" NP1216052.RAkF0qeHx6uRpmMBsq8ktf3c1yI-jl4O5V02wqWyGKI-s130_provenance.